Untitled
PDF) Genetic modifiers of -thalassemia and clinical severity as assessed by age at first transfusion | F. Anni and Stefania Satta - Academia.edu
Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia - ScienceDirect
Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities | ACS Chemical Biology
PDF) Altered Calcium and Red-ox homeostasis underline defective haematopoiesis in Fanconi Anemia
Anemie
Molecular analysis of Fanconi anemia: the
Ferrata Storti Foundation
Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase II, open-label, dose-finding study - UCL Discovery
Ferrata Storti Foundation
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchang
Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin | Haematologica
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension
Anemia nel neonato: cause, sintomi e terapia | GravidanzaOnLine
PDF) Hematologic responses in patients with aplastic anemia treated with deferasirox: A post hoc analysis from the EPIC study
PDF) Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies | Gian Forni - Academia.edu
PDF) Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology
Sociologia della scienza e della tecnologia - Carocci editore
Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy: Molecular Therapy
Pharmaceuticals | Free Full-Text | Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease
Vol. 103 No. 3 (2018): March, 2018 | Haematologica
Non-transfusion-dependent thalassemias
